Market
Fresh calamansi (calamondin; Citrus × microcarpa) in the United States is a niche fresh citrus used similarly to lemon or lime in cooking and beverages. UF/IFAS Extension describes calamondin/calamansi as a small, sour citrus that can fruit prolifically year-round under Florida-growing conditions, supporting limited domestic availability via home and container cultivation in warm or protected settings. When sourced via imports, U.S. entry is highly compliance-driven: USDA APHIS sets commodity- and origin-specific plant-health requirements (including possible treatments) and FDA requires pre-arrival prior notice for food shipments. Commercial availability and program continuity are therefore sensitive to phytosanitary authorization and documentation quality, particularly for citrus categories with heightened pest and disease concerns.
Market RoleNiche domestic consumption market with limited domestic cultivation (home/container); imported supply is compliance-sensitive when used
Domestic RoleSpecialty citrus used as a culinary acidulant and flavoring fruit; limited domestic cultivation supports niche direct/local availability
SeasonalityUF/IFAS Extension notes calamondin/calamansi trees tend to produce fruit prolifically year-round in Florida-growing conditions; commercial market availability may vary by channel and import program timing.
Risks
Regulatory Compliance HighFor any imported fresh calamansi supply, market access can be blocked or severely delayed if USDA APHIS commodity/origin admissibility conditions (ACIR), required treatments, or required documents (e.g., permits/phytosanitary certificates when applicable) are not met; requirements can also change during pest or disease events via Federal Orders.Pre-validate commodity/origin requirements in APHIS ACIR, align treatment and documentation with the exporter and NPPO, and use an experienced customs broker to ensure complete ACE/APHIS and FDA filings before arrival.
Plant Health MediumU.S. citrus disease pressure is material: APHIS describes citrus greening (HLB) as one of the most serious citrus diseases with no cure and notes it is present in multiple U.S. states and territories; heightened plant-health vigilance increases scrutiny on citrus movements and can tighten safeguards.Monitor APHIS citrus disease updates and Federal Orders; avoid sourcing from non-compliant programs and ensure pest exclusion safeguards across packing and transport.
Quality MediumUF/IFAS Extension notes calamondin/calamansi fruit does not last long once harvested, increasing shrink risk if shipments experience delays at port or in distribution.Plan shorter lead times, prioritize rapid clearance readiness (documents and filings), and route to distributors with fast turnover in specialty produce channels.
Food Safety MediumFDA may detain shipments that appear to violate U.S. food requirements, and products with a history of violations can be subject to Import Alerts leading to detention without physical examination (DWPE).Implement FSVP hazard analysis and supplier performance evaluation, maintain strong supplier QA documentation, and check relevant FDA Import Alerts for product/firm risk before shipping.
Sustainability- Biosecurity and quarantine controls to prevent spread of regulated citrus pests and diseases (e.g., citrus greening/HLB and citrus canker) within the United States.
FAQ
What is the single biggest risk that can block imported fresh calamansi from entering the United States?Noncompliance with USDA APHIS commodity- and origin-specific import conditions can stop a shipment. APHIS notes requirements vary by commodity and country of origin (published in ACIR), can include required treatments, and can change during pest or disease events, including through Federal Orders.
Is FDA prior notice required when importing fresh calamansi into the United States?Yes. FDA requires prior notice for imported food shipments, including fruits, before the shipment arrives at the first U.S. port, and FDA may detain shipments that are not in compliance with U.S. requirements.
Why are citrus-related plant health controls particularly important in the U.S. context?APHIS describes citrus greening (HLB) as one of the most serious citrus diseases with no cure and notes it is present in multiple U.S. states and territories. Because citrus pests and diseases can have major impacts, citrus imports and movements are subject to heightened biosecurity and quarantine attention.